Personalized DNA Rx Analysis

The DNA Drug Report is specifically designed for chronic care patients, including those with diabetes, cancer, and heart disease, who are on multiple medications. This report provides a detailed analysis of patient-specific DNA data, helping healthcare providers understand how individuals are likely to respond to various medications. By mapping patient genotypes, the report aims to maximize drug therapy efficacy, minimize potential drug interactions, and enhance overall treatment outcomes.

High-risk medications, such as epinephrine, vasopressin, epoprostenol, insulin, heparin, magnesium sulfate, nitroprusside sodium, potassium chloride, potassium phosphates, promethazine, benzodiazepines, opiates, and medications administered by anesthesiology, require special safeguards to minimize the risk of errors that could lead to significant patient harm or even death. The DNA Drug Report aids in identifying these risks, allowing for tailored and safer medication management in healthcare institutions.

FSA & HSA are accepted as long as they have a major credit logo. Typically, either VISA or MasterCard.

#DNADrugReport #ChronicCare #DiabetesCare #CancerCare #HeartDisease #MultipleMedications #PatientSafety #GeneticTesting #DrugTherapy #MedicationManagement #HighRiskMedications #HealthcareSafety #GenotypeMapping #PersonalizedMedicine #DrugInteractions #HealthOutcomes #SafeMedication #PatientCare